INMD vs DOCS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Sep 09, 2026
INMD
DOCS
Investment Advisor Scores
DOCS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | INMD | DOCS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 10.4493 | 20.1613 | INMD |
| PEG Ratio | 2.9004 | 0.5895 | DOCS |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 0.0% | 7.3% | DOCS |
| Earnings Growth | -31.0% | -51.9% | INMD |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 54.1/100 | 48.4/100 | INMD |
| Profit Margin | 20.7% | 25.5% | DOCS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | BUY | HOLD | INMD |
Relative Price Performance (Last 90 Days)
Current Technical Phase
INMD
NeutralMixed signals - no dominant trend phase, RSI 48
DOCS
MarkupPrice above SMA50, rising 50-day trend (9.2% over 20 days), RSI 54
Fundamentals Snapshot
| Metric | INMD | DOCS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 10.9 | 15.8 |
| Trailing P/E | 12.2 | 28.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.1% |
| Gross Margin | 0.8% | 0.9% |
| Operating Margin | 0.1% | 0.2% |
| EPS | 1.21 | 0.86 |
| Dividend Yield | — | — |